MedPath

Optimal care at the end of life

Not Applicable
Conditions
Patients with life-limiting, chronic progressive oncological and non-oncological diseases, being in general practitioners care in the chosen Region.
Registration Number
DRKS00015108
Lead Sponsor
Medizinische Hochschule Hannover
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
127
Inclusion Criteria

a. General practitioners
Located GPs in targeted region, who are registered in the region within the duration of the project (independent by sex)

b. Deceased patients of targeted GPs practice
Deceased as a result of life-limiting, chronic progressive oncological and non-oncological diseases within period of observation and while in GPs care, age > 18 (independent of sex)

c. Remained relatives of deceased patients in GPs practice
Age > 18 and direct contact to deceased patient in the last phase of life (independent of sex)

d. Stakeholder in health region
Employed at least 1 year at interface to GPs practice (nursing service, nursing homes, hospitals, surgery) (independent of sex)

e. Health insurance data
Patient deceased as a result of life-limiting, chronic progressive oncological and non-oncological diseases within ZIP-Code of the targeted Region in 2016/2017 (t=0) or 2019/2020 (t=1), continuously assured, age > 18 (independent of sex)

Exclusion Criteria

b. and e.: Sudden death, which is not related to a life-limiting, chronic progressive oncological and non-oncological disease (e.g. traffic accident, heart attack without diagnosis of coronary heart disease)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
a.) Optimized care at the end of life- General practitioners perspective: GP-EoLC-I, written survey of the project’s general practitioners – Dimensions: clinical practice of the general practitioners, organization of palliative care (t=0 six months pre interventionem, t=1 six month post-interventionem) <br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath